Resverlogix Corp. (TSE:RVX)’s share price passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $1.22 and traded as low as $0.99. Resverlogix shares last traded at $0.99, with a volume of 79,719 shares traded.
The firm’s 50-day moving average is C$1.21 and its 200 day moving average is C$1.41. The firm has a market capitalization of $206.50 million and a PE ratio of 4.38.
About Resverlogix (TSE:RVX)
Resverlogix Corp., a development stage company, develops small molecule therapeutics for bromodomain and extra-terminal (BET) inhibitior in the United States and Canada. It is developing apabetalone (RVX-208), a small molecule selective BET bromodomain inhibitor that is in Phase III clinical trials for the treatment of patients with cardiovascular diseases, diabetes mellitus, chronic kidney diseases, renal diseases, peripheral artery diseases, orphan diseases, and neurodegenerative diseases.
Featured Story: Do back-end load funds outperform no-load funds?
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.